Skip to main content
Premium Trial:

Request an Annual Quote

Australia's Diamantina Institute to Use IO Informatics' Sentient Suite

NEW YORK (GenomeWeb News) – The Diamantina Institute at the University of Queensland will use IO Informatics’ software in its cancer research programs, the company said today.
 
The institute, which is situated at the Princess Alexandra Hospital in Brisbane, Australia, will use the company’s Sentient Life Science software suite in its efforts
 
“Our goal is to identify genes involved in common cancers such as cervical, breast, skin and prostate cancer,” Diamantina Deputy Director Tom Gonda said in a statement. Those studies require that the researchers “pull data and information from a cornucopia of sources, such as genomics, proteomics, high throughput analytical instruments and internet accessible databases,” and Sentient “answers that need,” he said.
 
Financial terms of the agreement were not released.
 
IO Informatics also recently formed an Informatics for Personalized Medicine Working Group aimed at creating partnerships with pharmaceutical companies, doctors, hospitals, and research institutes.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.